Effective December 31, 2022, Dr. Andrew I. McDonald and Christopher P. Lowe resigned as members of the board of directors (the Board) of Vincerx Pharma, Inc. (the Company). Dr. McDonald had served as a member of the Board since the initial public offering of LifeSci Acquisition Corp. in March 2020, and Mr. Lowe had served as a member of the Board and as chair of the Audit Committee of the Board since the Business Combination.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8771 USD | -5.69% | +20.15% | -25.67% |
Apr. 26 | Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday | MT |
Apr. 26 | Vincerx Pharma Prices Public Offering of Shares, Warrants | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.67% | 25.9M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- VINC Stock
- News Vincerx Pharma, Inc.
- Vincerx Pharma, Inc. Announces Resignation of Board of Directors